Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)
This grant funds research on causes, biological mechanisms, and early detection of non-hereditary early-onset cancers (ages 18-49) to inform prevention and control strategies.
Funder: National Institutes of Health
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Project period up to 2 years (exploratory/developmental) or 4–5 years (research project); award size not specified.
Summary: Supports research investigating causes, mechanisms, and early detection of non-hereditary early-onset cancers (ages 18–49).
Key Information: This is a forecasted opportunity; all deadlines are projected and subject to change.
Description
This forecasted grant from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), seeks applications to study the causes, biological mechanisms, and early detection strategies for sporadic non-hereditary early-onset cancers (EOCs) in individuals aged 18 to 49. The aim is to advance understanding of the increasing incidence of these cancers among young adults, focusing on identifying modifiable risk factors, elucidating underlying biological mechanisms, and improving identification of those at elevated risk. Both exploratory/developmental and full research project applications are welcomed, streamlining the process for investigators in this critical research area.
